Beyond the Bricks: How a $50M Grant Redefines Cancer Care in New England

BOSTON, MA – June 09, 2026 – In a move that signals a monumental shift in New England's healthcare landscape, the Yawkey Foundation has bestowed a historic $50 million grant upon the Dana-Farber Cancer Institute. This contribution, the largest from the foundation in its eight-decade history, is set to catalyze a new era of cancer care, funding both the construction of a landmark dedicated cancer hospital and a comprehensive "Future of Cancer Care Fund." The grant is not merely a financial transaction; it is the latest chapter in a profound, 75-year partnership built on a shared vision to eradicate the burden of cancer.

The investment aims to do more than just erect a new building. It seeks to fundamentally reshape the patient experience, accelerate scientific discovery, and create a new paradigm for integrated oncology care in a region known for its medical prowess. For an institution like Dana-Farber, which has long prided itself on a unique balance of research and patient care, this grant provides the fuel to build the physical and programmatic infrastructure for the next generation of cancer treatment.

"We’re profoundly grateful for the Yawkey Foundation’s visionary generosity," said Dr. Benjamin L. Ebert, president and CEO of Dana-Farber Cancer Institute. "This grant exemplifies the Yawkey Foundation’s enduring legacy that has made an incredible impact on cancer care and research. Their transformational grant will advance groundbreaking research, innovative treatments and patient-centered care, while supporting the future cancer hospital at Dana-Farber Cancer Institute."

A New Blueprint for Cancer Care

At the heart of this transformation is the planned 14-floor, 450,000-square-foot facility that will become New England's only dedicated adult cancer hospital. With 300 private inpatient rooms, the hospital is being designed from the ground up with a singular focus: the complex needs of cancer patients and their families. This is a significant departure from the traditional model where cancer care is often delivered within the sprawling, multi-specialty environment of a general hospital.

The design prioritizes a patient-centered experience, with rooms large enough to comfortably accommodate family members and advanced air systems engineered to protect immunocompromised patients. The integration of care is a core tenet of the project. A new bridge, to be named in honor of Jean and Tom Yawkey, will span Brookline Avenue, providing a crucial physical and symbolic link between the existing Yawkey Center for Cancer Care and the new inpatient hospital. This will create a seamless campus, ensuring patients can move effortlessly between outpatient and inpatient services within a medical environment focused exclusively on their condition.

"The Yawkey Foundation grant embodies the Yawkey family’s long-standing commitment to Dana-Farber's revolutionary science and innovation," noted Dana-Farber board chair Josh Bekenstein. "Their generous support will enhance Dana-Farber's vision for delivering seamless, comprehensive and specialized care." The project is also a significant economic driver for the region, with plans to create approximately 2,400 new jobs and recruit over 200 additional physicians in the coming years.

Eight Decades in the Making

This $50 million grant is the culmination of a partnership that predates the modern era of oncology. More than 75 years ago, Boston Red Sox owners Tom and Jean Yawkey were among the first to support the pioneering vision of Dr. Sidney Farber, founder of what was then the Children's Cancer Research Foundation. Their initial private funding helped lay the groundwork for a revolution in cancer research.

Tom Yawkey's commitment was deeply personal, serving on Dana-Farber's Board of Trustees from 1954 until his death in 1976, including terms as president and chairman. Jean Yawkey continued this legacy, serving as a trustee and chair herself. This deep-seated belief in the mission led to one of the most iconic and enduring partnerships in professional sports: the alliance between the Boston Red Sox and the Jimmy Fund. Forged in 1953, this relationship has raised hundreds of millions of dollars and brought the fight against cancer into the hearts of communities across New England.

"Tom Yawkey's devotion to Dr. Sidney Farber and his pioneering vision was absolute and personal — he believed from the very beginning that the Children's Cancer Research Foundation [now known as Dana-Farber] represented one of the most important endeavors of his lifetime," said John L. Harrington, Yawkey Foundation chairman. This historic grant builds upon previous transformative gifts, including a $30 million grant in 2007 that helped build the Yawkey Center for Cancer Care, underscoring a consistent, long-term strategy of investing in world-class infrastructure and care.

Beyond Bricks and Mortar: Fueling Future Discoveries

While the new hospital provides the state-of-the-art physical plant, a significant portion of the grant is dedicated to the "Future of Cancer Care Fund," an initiative designed to power the science and support systems within the building's walls. This fund is a strategic investment in the intellectual capital and holistic care models that define modern oncology.

The funding will accelerate groundbreaking research, reinforcing the "bench-to-bedside" model that allows scientific discoveries to be rapidly translated into novel therapies for patients. The new hospital is designed to facilitate this, creating feedback loops where clinical observations from the "bedside-to-bench" can inform new avenues of scientific inquiry.

Beyond the lab, the fund will bolster programs that address the totality of the patient experience. This includes advancing early detection methods to improve outcomes, expanding survivorship programs to address the long-term needs of patients post-treatment, and enhancing psychosocial services that support the mental and emotional well-being of patients and their families. It also provides for patient assistance, ensuring that financial barriers do not stand in the way of receiving world-class care.

"Cancer touches virtually every family in some way, and the urgency of that reality is precisely why this grant matters so deeply," stated Alicia Verity, CEO of the Yawkey Foundation. "With this investment, Dana-Farber can continue to lead New England and the world in transforming the future of cancer research and care."

Reshaping the Regional Healthcare Ecosystem

The establishment of New England's only dedicated adult cancer hospital is poised to send ripples throughout the regional healthcare landscape. By concentrating expertise, resources, and technology in a single, purpose-built facility, Dana-Farber is making a bold statement about the benefits of specialized care. This model allows for the creation of highly specialized teams of experts focused on specific cancer types, fostering a depth of knowledge and collaborative care that can be challenging to replicate in a general hospital setting.

This strategic expansion is not limited to inpatient services. The institute recently announced plans for a new ambulatory care building in Brighton, set to open in 2029, which will further increase its capacity for outpatient services like infusion, imaging, and clinical trials. Together, these projects represent a comprehensive strategy to meet the growing demand for cancer services and solidify Dana-Farber's position as a global leader. For patients and families across New England and beyond, this investment represents more than just a new building; it is a powerful symbol of hope and a tangible commitment to a future free from the fear of cancer.